搜尋結果
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for ...
Bastillepost· 7 日前ImmunityBio, Inc. ( NASDAQ: IBRX ), an immunotherapy company, today announced that the U.S. ...
NOAA, CDC Launch HeatRisk, a Tool to Forecast Dangerous Heat
Bloomberg· 7 日前HeatRisk combines weather forecasts with heat-related health data to predict when high ...
U.S. FDA approves ImmunityBio's bladder cancer therapy
Reuters· 7 日前, opens new tab combination therapy to treat a type of bladder cancer, marking an end to the ...
FTC Ban On Noncompete Agreements May Undermine Your Estate Plan
Forbes· 3 日前What do the FTC and its new restrictions on noncompete agreements have to do with estate ...
High number of paediatric cases recorded in ongoing influenza season - Dimsum Daily
Dimsum Daily· 4 日前25th April 2024 – (Hong Kong) According to the latest data released by the Centre for Health ...
Opinion | The FTC Decrees: No More Non-Compete Agreements
The Wall Street Journal· 5 日前Lina Khan’s latest rule instantly invalidates 30 million contracts without Congressional authority.
Author Post: Can AI-Powered Coaches Help to Save Healthcare?
Forbes· 5 日前There’s an immense amount of discussion these days about how AI is changing the world, and ...
France's Orange meets Q1 core operating profit estimate on upbeat revenue growth
Reuters· 5 日前Telecoms groups raised prices to offset the impact of inflation amid a less dynamic market, and ...
China’s Credit Yields Drop to Record Lows on Bond Bull Run
Bloomberg· 6 日前China’s local credit yields have fallen to the lowest level ever as investors load up on ...
台新投信攜荷寶基金 2024投資亮點看好消費趨勢 科技七巨頭續強
鉅亨網 via Yahoo財經香港· 4 日前台新投信 2024 年正式總代理荷寶基金,展望 2024 年投資亮點 ,荷寶環球消費新趨勢股票基金經理人 ...